Professor of Medicine Director, Masonic Cancer Center, University of Minnesota
Oncology
Dr. Douglas Yee, MD
|
|
Give Review
Douglas is an expert in the field of Oncology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Douglas Yee, MD is a published doctor and has 24 publications published. The lastest was: 'Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.'
Publications
- Minireview: Were the IGF Signaling Inhibitors All Bad?
- The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer.
- eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells.
- A phase I feasibility study of multi-modality imaging assessing rapid expansion of marrow fat and decreased bone mineral density in Cancer patients.
- Validation of marrow fat assessment using noninvasive imaging with histologic examination of human bone samples.
- Insulin-Like Growth Factors, Insulin, and Growth Hormone Signaling in Breast Cancer: Implications for Targeted Therapy.
- A Tale of Two Receptors: Insulin and Insulin-Like Growth Factor Signaling in Cancer.
- IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC-.
- A Dual-Radioisotope Hybrid Whole-Body Micro-Positron Emission Tomography/Computed Tomography System Reveals Functional Heterogeneity and Early Local and Systemic Chang...
- Progesterone receptor-B enhances estrogen responsiveness of breast Cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.
- Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast Cancer cells.
- Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials.
- Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic Cancer patients.
- APOBEC3B is an enzymatic source of mutation in breast Cancer.
- The Influence of Therapeutic Radiation on the Patterns of Bone Remodeling in Ovary-Intact and Ovariectomized Mice.
- BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization.
- Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development.
- The influence of therapeutic radiation on the patterns of bone marrow in ovary-intact and ovariectomized mice.
- Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment.
- Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast Cancer treatment.
- Spatial and temporal fracture pattern in breast and gynecologic Cancer survivors.
- Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast Cancer cells.
- Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Clinical Center At The Nih
University Of Nc Hosps
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Conditions Treated
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- Tricare
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
National Institutes of Health Clinical Center -
University of North Carolina Hospitals -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1598851198 | |
| NPPES Provider LastName | YEE | |
| NPPES Provider FirstName | DOUGLAS | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 55.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598851198 |
| Last Name Of The Provider | YEE |
| First Name Of The Provider | DOUGLAS |
| View All |
Similar Doctors
|
|
Dr. Stuart H. Bloom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emil Lou, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nadia Q. Rehman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale E. Hammerschmidt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark A. Wilkowske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andres R. Wiernik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Manion, MD
This Doctor is OpenDoctor Recommended.
|